These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16862428)

  • 1. R-Ras promotes metastasis of cervical cancer epithelial cells.
    Mora N; Rosales R; Rosales C
    Cancer Immunol Immunother; 2007 Apr; 56(4):535-44. PubMed ID: 16862428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R-Ras promotes tumor growth of cervical epithelial cells.
    Rincón-Arano H; Rosales R; Mora N; Rodriguez-Castañeda A; Rosales C
    Cancer; 2003 Feb; 97(3):575-85. PubMed ID: 12548599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced increase in cell migration and metastatic potential of cervical cancer cells operates via the K-Ras pathway.
    Su WH; Chuang PC; Huang EY; Yang KD
    Am J Pathol; 2012 Feb; 180(2):862-71. PubMed ID: 22138581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.
    Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M
    Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ; Wang Y; Wang YY
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway.
    Feng T; Zheng L; Liu F; Xu X; Mao S; Wang X; Liu J; Lu Y; Zhao W; Yu X; Tang W
    Oncotarget; 2016 Sep; 7(36):58381-58395. PubMed ID: 27517315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
    Liu H; Zhang L; Ding X; Sui X
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
    Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways.
    Li Y; Cui N; Zheng PS; Yang WT
    Oncotarget; 2017 Jul; 8(30):49238-49252. PubMed ID: 28514765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular regulation of cervical cancer growth and invasion by VEGFa.
    Chen B; Zhang C; Dong P; Guo Y; Mu N
    Tumour Biol; 2014 Nov; 35(11):11587-93. PubMed ID: 25135429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration.
    Yadav V; Denning MF
    Mol Carcinog; 2011 May; 50(5):346-52. PubMed ID: 21480388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake.
    Rashmi R; DeSelm C; Helms C; Bowcock A; Rogers BE; Rader JL; Rader J; Grigsby PW; Schwarz JK
    PLoS One; 2014; 9(4):e92948. PubMed ID: 24705275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
    Teng P; Jiao Y; Hao M; Tang X
    J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sur8/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling.
    Kaduwal S; Jeong WJ; Park JC; Lee KH; Lee YM; Jeon SH; Lim YB; Min do S; Choi KY
    Oncotarget; 2015 Oct; 6(32):33091-105. PubMed ID: 26384305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer.
    Yang X; Feng KX; Li H; Wang L; Xia H
    Technol Cancer Res Treat; 2020; 19():1533033820942245. PubMed ID: 32856542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
    Zhang X; Liu S; Zhu Y
    Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations.
    Konstantinidou G; Bey EA; Rabellino A; Schuster K; Maira MS; Gazdar AF; Amici A; Boothman DA; Scaglioni PP
    Cancer Res; 2009 Oct; 69(19):7644-52. PubMed ID: 19789349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway.
    Li B; Tsao SW; Li YY; Wang X; Ling MT; Wong YC; He QY; Cheung AL
    Int J Cancer; 2009 Dec; 125(11):2576-85. PubMed ID: 19551863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
    Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C
    Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.